Myeloproliferative neoplasm epidemiology and demographics: Difference between revisions
| Line 11: | Line 11: | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with myeloproliferative neoplasm than females. | Males are more commonly affected with myeloproliferative neoplasm than females. | ||
===Race=== | |||
The prevalence of myeloproliferative neoplasm does not vary by race. | |||
==References== | ==References== | ||
Revision as of 17:12, 22 October 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm epidemiology and demographics |
|
FDA on Myeloproliferative neoplasm epidemiology and demographics |
|
on Myeloproliferative neoplasm epidemiology and demographics |
|
Myeloproliferative neoplasm epidemiology and demographics in the news |
|
Blogs on Myeloproliferative neoplasm epidemiology and demographics |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.[1]
Epidemiology and Demographics
Incidence
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.[1]
Age
The prevalence of myeloproliferative neoplasm increases with age.
Gender
Males are more commonly affected with myeloproliferative neoplasm than females.
Race
The prevalence of myeloproliferative neoplasm does not vary by race.